Last update 21 Nov 2024

Anti-CEA CAR T cell therapy(Shanghai Genechem Co., Ltd.)

Overview

Basic Info

Drug Type
Autologous CAR-T
Synonyms
MG7-CART
Target
CEACAM5
Mechanism
CEACAM5 antagonists(Carcinoembryonic antigen related cell adhesion molecule 5 antagonists)
Therapeutic Areas
NeoplasmsDigestive System Disorders
Active Indication
Liver CancerColorectal Cancer
Inactive Indication
Liver metastases
Originator Organization
Shanghai Genechem Co., Ltd.Shanghai Genechem Co., Ltd.
Active Organization
Shanghai Genechem Co., Ltd.Shanghai Genechem Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Anti-CEA CAR T cell therapy(Shanghai Genechem Co., Ltd.)
NCT02862704 / Unknown statusPhase 1/2IIT
An Open-label, Uncontrolled, Single-arm Pilot Study to Evaluate Safety and Efficacy of Intratumoral Delivery Mediated MG7-targeted Chimeric Antigen Receptor T Cells in Advanced MG7 Positive Liver Metastases
100 Clinical Results associated with Anti-CEA CAR T cell therapy(Shanghai Genechem Co., Ltd.)
Login to view more data
100 Translational Medicine associated with Anti-CEA CAR T cell therapy(Shanghai Genechem Co., Ltd.)
Login to view more data
100 Patents (Medical) associated with Anti-CEA CAR T cell therapy(Shanghai Genechem Co., Ltd.)
Login to view more data
100 Deals associated with Anti-CEA CAR T cell therapy(Shanghai Genechem Co., Ltd.)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Liver CancerPhase 2
CN
Shanghai Genechem Co., Ltd.Shanghai Genechem Co., Ltd.
-
Colorectal CancerPhase 1
CN
Shanghai Genechem Co., Ltd.Shanghai Genechem Co., Ltd.
-
Liver metastasesDiscovery
CN
Shanghai Genechem Co., Ltd.Shanghai Genechem Co., Ltd.
01 Jun 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
AACR2018
Not Applicable
Metastatic colon cancer
-
fkifyyjqkh(znhskbtvbx) = During the treatment, the patient experienced cytokine release dbahsbbiiy (cfzameqboc )
View more
Positive
01 Jul 2018
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free